Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Fast monocyte-derived dendritic cell-based immunotherapy.

Ramadan G.

Methods Mol Biol. 2014;1139:131-44. doi: 10.1007/978-1-4939-0345-0_12.

PMID:
24619676
2.
3.

Generation of Aspergillus- and CMV- specific T-cell responses using autologous fast DC.

Ramadan G, Konings S, Kurup VP, Keever-Taylor CA.

Cytotherapy. 2004;6(3):223-34.

PMID:
15203979
4.

Large-scale monocyte enrichment coupled with a closed culture system for the generation of human dendritic cells.

Pullarkat V, Lau R, Lee SM, Bender JG, Weber JS.

J Immunol Methods. 2002 Sep 15;267(2):173-83.

PMID:
12165439
5.

Human dendritic cells pulsed with specific lipopeptides stimulate autologous antigen-specific T cells without the addition of exogenous maturation factors.

Jones KL, Brown LE, Eriksson EM, Ffrench RA, Latour PA, Loveland BE, Wall DM, Roberts SK, Jackson DC, Gowans EJ.

J Viral Hepat. 2008 Oct;15(10):761-72. doi: 10.1111/j.1365-2893.2008.01003.x.

PMID:
18637077
6.

Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturation.

Schaft N, Dörrie J, Thumann P, Beck VE, Müller I, Schultz ES, Kämpgen E, Dieckmann D, Schuler G.

J Immunol. 2005 Mar 1;174(5):3087-97. Erratum in: J Immunol. 2005 May 1;174(9):5884.

7.
8.

Enhancement of anti-tumor cytotoxicity of expanded gammadelta T Cells by stimulation with monocyte-derived dendritic cells.

Saito A, Narita M, Yokoyama A, Watanabe N, Tochiki N, Satoh N, Takizawa J, Furukawa T, Toba K, Fuse I, Aizawa Y, Shinada S, Takahashi M.

J Clin Exp Hematop. 2007 Nov;47(2):61-72. Erratum in: J Clin Exp Hematop. 2008 Apr;48(1):33.

9.

In vitro immunization and expansion of antigen-specific cytotoxic T lymphocytes for adoptive immunotherapy using peptide-pulsed dendritic cells.

Tsai V, Kawashima I, Keogh E, Daly K, Sette A, Celis E.

Crit Rev Immunol. 1998;18(1-2):65-75. Review.

PMID:
9419449
10.

Cytomegalovirus-specific cytolytic T-cell lines and clones generated against adenovirus-pp65-infected dendritic cells.

Keever-Taylor CA, Margolis D, Konings S, Sandford GR, Nicolette CA, Lawendowski C, Burns WH.

Biol Blood Marrow Transplant. 2001;7(5):247-56.

11.

Effective clinical-scale production of dendritic cell vaccines by monocyte elutriation directly in medium, subsequent culture in bags and final antigen loading using peptides or RNA transfection.

Erdmann M, Dörrie J, Schaft N, Strasser E, Hendelmeier M, Kämpgen E, Schuler G, Schuler-Thurner B.

J Immunother. 2007 Sep;30(6):663-74.

PMID:
17667530
12.

Large-scale generation of mature monocyte-derived dendritic cells for clinical application in cell factories.

Berger TG, Feuerstein B, Strasser E, Hirsch U, Schreiner D, Schuler G, Schuler-Thurner B.

J Immunol Methods. 2002 Oct 15;268(2):131-40.

PMID:
12215381
13.
14.
15.

Induction of antigen-specific cytotoxic T lymphocytes by using monocyte-derived DCs transfected with in vitro-transcribed WT1 or SART1 mRNA.

Narita M, Tochiki N, Saitoh A, Watanabe N, Kaji M, Satoh N, Yamahira A, Nakamura T, Masuko M, Furukawa T, Toba K, Fuse I, Aizawa Y, Takahashi M.

Med Oncol. 2009 Dec;26(4):429-36. doi: 10.1007/s12032-008-9142-3.

PMID:
19058036
16.

A full scale comparative study of methods for generation of functional Dendritic cells for use as cancer vaccines.

Jarnjak-Jankovic S, Hammerstad H, Saebøe-Larssen S, Kvalheim G, Gaudernack G.

BMC Cancer. 2007 Jul 3;7:119.

17.

FastDC derived from human monocytes within 48 h effectively prime tumor antigen-specific cytotoxic T cells.

Dauer M, Schad K, Herten J, Junkmann J, Bauer C, Kiefl R, Endres S, Eigler A.

J Immunol Methods. 2005 Jul;302(1-2):145-55.

PMID:
15992809
18.

In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line.

Santegoets SJ, Schreurs MW, Masterson AJ, Liu YP, Goletz S, Baumeister H, Kueter EW, Lougheed SM, van den Eertwegh AJ, Scheper RJ, Hooijberg E, de Gruijl TD.

Cancer Immunol Immunother. 2006 Dec;55(12):1480-90.

PMID:
16468034
19.
20.

Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adeno-associated virus/human papillomavirus type 16 E7 antigen gene transduction into dendritic cells.

Chiriva-Internati M, Liu Y, Salati E, Zhou W, Wang Z, Grizzi F, Roman JJ, Lim SH, Hermonat PL.

Eur J Immunol. 2002 Jan;32(1):30-8.

Items per page

Supplemental Content

Support Center